PBYI icon

Puma Biotechnology
PBYI

Overview Fund Activity

119 hedge funds and large institutions have $319M invested in Puma Biotechnology in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 13 closing their positions.

Holders
119
Holders Change
+2
Holders Change %
+1.71%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
47
Reduced
39
Closed
13
Calls
$1.13M
Puts
$696K
Net Calls
+$430K
Net Calls Change
+$273K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$1.99M
2
CCM
2
Camber Capital Management
Massachusetts
$25M
3
ACM
3
AIGH Capital Management
Maryland
$10.2M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$2.58M
5
Prudential Financial
5
Prudential Financial
New Jersey
$3.53M

Top Sellers

1
State Street
1
State Street
Massachusetts
$14M
2
FAM
2
Fred Alger Management
New York
$27.4M
3
Goldman Sachs
3
Goldman Sachs
New York
$3.55M
4
SI
4
Sofinnova Investments
California
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.02M
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
126
SG Americas Securities
New York
– -$146K -14,983 Closed
Jane Street
127
Jane Street
New York
– -$110K -11,257 Closed
MLICM
128
Metropolitan Life Insurance Company (MetLife)
New York
– -$76.7K -7,892 Closed
FC
129
FORA Capital
Florida
– -$34K -3,470 Closed
Pacer Advisors
130
Pacer Advisors
Pennsylvania
– -$28K -2,837 Closed
MIM
131
MetLife Investment Management
New Jersey
– -$23.3K -2,392 Closed
TCOV
132
Trust Company of Vermont
Vermont
– -$1K -100 Closed
2 3 4 5
6